SRA1 and central nervous system cancer: Immunohistochemical (IHC) analysis in 136 human glioma samples showed that SR-A1 expression increased with glioma grade (Figure 1Aa & 1Ab), suggesting that SR-A1 might be associated with malignant glioma initiation and progression.